XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone972-9955-7080
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/7/2019 (Estimated)
OptionableNot Optionable
X T L Biopharmaceuticals (NASDAQ:XTLB) Frequently Asked Questions
What is X T L Biopharmaceuticals' stock symbol?
X T L Biopharmaceuticals trades on the NASDAQ under the ticker symbol "XTLB."
When did X T L Biopharmaceuticals' stock split? How did X T L Biopharmaceuticals' stock split work?
Shares of X T L Biopharmaceuticals reverse split on Friday, February 10th 2017. The 1-5 reverse split was announced on Wednesday, January 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 9th 2017. An investor that had 100 shares of X T L Biopharmaceuticals stock prior to the reverse split would have 20 shares after the split.
When is X T L Biopharmaceuticals' next earnings date?
Has X T L Biopharmaceuticals been receiving favorable news coverage?
Media coverage about XTLB stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. X T L Biopharmaceuticals earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the biopharmaceutical company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the company's share price in the near future. View News Stories for X T L Biopharmaceuticals.
Who are some of X T L Biopharmaceuticals' key competitors?
Some companies that are related to X T L Biopharmaceuticals include Sernova (SEOVF), Adamis Pharmaceuticals (ADMP), Jaguar Health (JAGX), China SXT Pharmaceuticals (SXTC), Bellerophon Therapeutics (BLPH), Acer Therapeutics (ACER), Addex Therapeutics (ADDXF), Zosano Pharma (ZSAN), Leap Therapeutics (LPTX), Clearside Biomedical (CLSD), Fibrocell Science (FCSC), Akari Therapeutics (AKTX), Alimera Sciences (ALIM), Bio-Path (BPTH) and Zafgen (ZFGN).
What other stocks do shareholders of X T L Biopharmaceuticals own?
Who are X T L Biopharmaceuticals' key executives?
X T L Biopharmaceuticals' management team includes the folowing people:
- Mr. Joshua Levine, Chief Exec. Officer (Age 53)
- Mr. Itay Weinstein, Chief Financial Officer (Age 48)
- Mr. Ronen Kantor Adv, Company Sec.
How do I buy shares of X T L Biopharmaceuticals?
Shares of XTLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is X T L Biopharmaceuticals' stock price today?
One share of XTLB stock can currently be purchased for approximately $1.67.
How big of a company is X T L Biopharmaceuticals?
What is X T L Biopharmaceuticals' official website?
How can I contact X T L Biopharmaceuticals?
X T L Biopharmaceuticals' mailing address is 5 HACHAROSHET ST., RAANANA L3, 43656. The biopharmaceutical company can be reached via phone at 972-9955-7080 or via email at [email protected]
MarketBeat Community Rating for X T L Biopharmaceuticals (NASDAQ XTLB)
MarketBeat's community ratings are surveys of what our community members think about X T L Biopharmaceuticals and other stocks. Vote "Outperform" if you believe XTLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XTLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
